RT Journal Article SR Electronic T1 Deep Learning Based Long Term Mortality Prediction in the National Lung Screening Trial JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.01.12.22269152 DO 10.1101/2022.01.12.22269152 A1 Yaozhi Lu A1 Shahab Aslani A1 Mark Emberton A1 Daniel C. Alexander A1 Joseph Jacob YR 2022 UL http://medrxiv.org/content/early/2022/01/13/2022.01.12.22269152.abstract AB In this study, the long-term mortality in the National Lung Screening Trial (NLST) was investigated using a deep learning-based method. Binary classification of the non-lung-cancer mortality (i.e. cardiovascular and respiratory mortality) was performed using neural network models centered around a 3D-ResNet. The models were trained on a participant age, gender, and smoking history matched cohort. Utilising both the 3D CT scan and clinical information, the models can achieve an AUC of 0.73 which outperforms humans at cardiovascular mortality prediction. By interpreting the trained models with 3D saliency maps, we examined the features on the CT scans that correspond to the mortality signal. The saliency maps can potentially assist the clinicians’ and radiologists’ to identify regions of concern on the image that may indicate the need to adopt preventative healthcare management strategies to prolong the patients’ life expectancy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the International Alliance for Cancer Early Detection, an alliance between Cancer Research UK [C23017/A27935], Canary Center at Stanford University, the University of Cambridge, OHSU Knight Cancer Institute, University College London and the University of Manchester.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from the National Lung Screening Trial (https://www.cancer.gov/types/lung/research/nlst).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.